$40.66
1.523.88%
At close: -
$40.90
0.240.59%
After Hours: Dec 20, 7:54 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Kymera Therapeutics in recent months.
Browse guidance and forecast on all stocks.